Xichen Lin
CHIEF SCIENTIFIC OFFICER · Structure Therapeutics Inc.
- 2025
- Sep 3, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Xichen Lin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- FMR LLC - $7.06M in GPCR purchases and sales in the last 12 months
- Crespo Blas Coll - $145K in GPCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Xichen Lin?
Xichen Lin is a corporate insider, tracked as CHIEF SCIENTIFIC OFFICER of Structure Therapeutics Inc. (GPCR). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Xichen Lin submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Xichen Lin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($1.47M) across all tracked filings.
